RecruitingPhase 1NCT05136846
Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer
Studying Mitochondrial disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Principal Investigator
- Jeremey Brownstein, MDOhio State University Comprehensive Cancer Center
- Intervention
- Carboplatin(drug)
- Enrollment
- 28 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2021 – 2026
Study locations (2)
- City of Hope, Duarte, California, United States
- Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05136846 on ClinicalTrials.govOther trials for Mitochondrial disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06880406Mitochondrial Function and Metabolomic Profile in Alzheimer's Disease and Related DementiasCentre Hospitalier Universitaire de Nice
- RECRUITINGPHASE1NCT06834126Papaverine in Combination With Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer, DINOMITE TrialCity of Hope Medical Center
- RECRUITINGNCT06890520Neurometabolic Profile of Individuals With Primary Mitochondrial DiseaseChildren's Hospital of Philadelphia
- RECRUITINGPHASE1NCT06819683Validation of Nanosensor Oxygen MeasurementChildren's Hospital of Philadelphia
- RECRUITINGNANCT06535646Digital Health Technology for People With Mitochondrial DiseaseNeuroscience Research Australia
- ENROLLING BY INVITATIONNCT06450964Establishment of Reproductive Cohort and Prediction Model of Genetic Counseling for Mitochondrial Genetic DiseasesAnhui Medical University
- RECRUITINGNCT06504433The Natural History of Mitochondrial DiseasesNeuroscience Research Australia
- RECRUITINGNCT06213103Mitochondrial Disease-associated ImmunoDeficienciesUniversity Hospital, Bordeaux